BACKGROUND: Serum ferritin was discovered in the 1930s, and was developed as a
clinical test in the 1970s. Many diseases are associated with iron overload or iron deficiency …

Haematopoietic stem cell transplantation (HCT) is the treatment of choice for defined
malignant and non‐malignant haematological disorders. The main drawbacks of HCT are …

Iron overload is common in patients undergoing allogeneic hematopoietic cell
transplantation (HCT) for hematologic disorders. Serum ferritin, a marker of tissue iron …

Elevated pretransplant serum ferritin levels have been associated with an increased
incidence of morbidity and mortality after allogeneic haematopoietic stem cell …

Extracorporeal photopheresis (ECP) has been shown to be a promising treatment for
chronic graft-versus-host disease; however, only a few case reports are available that …

Clinical research examining the role of hematopoietic stem cell transplantation (SCT) in the
therapy of myelodysplastic syndromes (MDS) in adults is presented and critically evaluated …

Background This retrospective study was aimed at establishing a clinical score to stratify the
risk of cytomegalovirus (CMV) reactivation in patients undergoing allogeneic hematopoietic …

Anemia leading to transfusion dependency (TD) and iron overload (IO) is commonly
observed in patients with myelodysplastic syndromes (MDS). In MDS, TD and IO have been …

Recipients of hematopoietic stem cell transplantation (HSCT) frequently have iron overload
resulting from chronic transfusion therapy for anemia. In some cases, for example, in …

The myelodysplastic syndromes (MDS) are characterized by cytopenias and acute myeloid
leukemia risk. Most MDS patients eventually require transfusion of red blood cells for …